PainChek Toekomstige groei
Future criteriumcontroles 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for PainChek.
Belangrijke informatie
n/a
Groei van de winst
n/a
Groei van de winst per aandeel
| Healthcare Services winstgroei | 20.9% |
| Inkomstengroei | n/a |
| Toekomstig rendement op eigen vermogen | n/a |
| Dekking van analisten | None |
| Laatst bijgewerkt | n/a |
Recente toekomstige groei-updates
When Can We Expect A Profit From PainChek Limited (ASX:PCK)?
May 07
Market Sentiment Around Loss-Making PainChek Limited (ASX:PCK)
Nov 20Recent updates
We're Keeping An Eye On PainChek's (ASX:PCK) Cash Burn Rate
Jul 04Is PainChek (ASX:PCK) In A Good Position To Invest In Growth?
Feb 08Will PainChek (ASX:PCK) Spend Its Cash Wisely?
Jul 05Companies Like PainChek (ASX:PCK) Can Afford To Invest In Growth
Jan 26We're Interested To See How PainChek (ASX:PCK) Uses Its Cash Hoard To Grow
Sep 07When Can We Expect A Profit From PainChek Limited (ASX:PCK)?
May 07PainChek (ASX:PCK) Is In A Strong Position To Grow Its Business
Mar 01Market Sentiment Around Loss-Making PainChek Limited (ASX:PCK)
Nov 20In dit gedeelte presenteren we gewoonlijk prognoses voor de omzet- en winstgroei op basis van de consensusramingen van professionele analisten om beleggers te helpen begrijpen in hoeverre het bedrijf in staat is winst te genereren. Maar omdat PainChek onvoldoende gegevens uit het verleden heeft verstrekt en geen analistenprognose heeft, kan de toekomstige winst niet betrouwbaar worden berekend door gegevens uit het verleden te extrapoleren of analistenprognoses te gebruiken.
Dit is een vrij zeldzame situatie, aangezien 97% van de bedrijven die worden gedekt door SimplyWall St wel financiële gegevens uit het verleden hebben.
Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 6/30/2024 | 3 | -8 | -7 | -7 | N/A |
| 3/31/2024 | 3 | -8 | -7 | -7 | N/A |
| 12/31/2023 | 2 | -8 | -6 | -6 | N/A |
| 9/30/2023 | 2 | -8 | -6 | -6 | N/A |
| 6/30/2023 | 2 | -8 | -6 | -6 | N/A |
| 3/31/2023 | 2 | -7 | -6 | -6 | N/A |
| 12/31/2022 | 1 | -7 | -6 | -6 | N/A |
| 9/30/2022 | 1 | -6 | -6 | -6 | N/A |
| 6/30/2022 | 1 | -6 | -7 | -7 | N/A |
| 3/31/2022 | 1 | -6 | -7 | -7 | N/A |
| 12/31/2021 | 0 | -7 | -6 | -6 | N/A |
| 9/30/2021 | 0 | -6 | -5 | -5 | N/A |
| 6/30/2021 | 0 | -6 | -4 | -4 | N/A |
| 3/31/2021 | 0 | -5 | -4 | -3 | N/A |
| 12/31/2020 | 0 | -4 | -3 | -3 | N/A |
| 9/30/2020 | 0 | -8 | -2 | -2 | N/A |
| 6/30/2020 | 0 | -12 | -2 | -2 | N/A |
| 3/31/2020 | 0 | -12 | -3 | -3 | N/A |
| 12/31/2019 | 0 | -12 | -4 | -4 | N/A |
| 9/30/2019 | 0 | -8 | -4 | -4 | N/A |
| 6/30/2019 | 0 | -3 | -3 | -3 | N/A |
| 3/31/2019 | 0 | -3 | -3 | -3 | N/A |
| 12/31/2018 | 0 | -3 | -3 | -3 | N/A |
| 9/30/2018 | 0 | -4 | -3 | -3 | N/A |
| 6/30/2018 | 0 | -5 | -3 | -3 | N/A |
| 3/31/2018 | 0 | -5 | N/A | -3 | N/A |
| 12/31/2017 | 0 | -5 | N/A | -3 | N/A |
| 9/30/2017 | 0 | -7 | N/A | -2 | N/A |
| 6/30/2017 | 0 | -8 | N/A | -2 | N/A |
| 6/30/2016 | 0 | 0 | N/A | 0 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: Insufficient data to determine if PCK's forecast earnings growth is above the savings rate (2.4%).
Winst versus markt: Insufficient data to determine if PCK's earnings are forecast to grow faster than the Australian market
Hoge groeiwinsten: Insufficient data to determine if PCK's earnings are expected to grow significantly over the next 3 years.
Omzet versus markt: Insufficient data to determine if PCK's revenue is forecast to grow faster than the Australian market.
Hoge groei-inkomsten: Insufficient data to determine if PCK's revenue is forecast to grow faster than 20% per year.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Insufficient data to determine if PCK's Return on Equity is forecast to be high in 3 years time